Navigation Links
DRAXIS Health Reports Fourth Quarter and Year End Results
Date:2/7/2008

external factors such as customer changes to the timing of product demand and delivery and a shortage of medical isotopes constrained profitability in the fourth quarter, these are short term factors that we believe will have minimal impact going forward."

Mr. Brazier also noted, "For the longer term, 2007 saw the completion of all non-financial milestones that contributed to the progress of key initiatives that will drive long term growth beginning in 2008. We filed submissions for DRAXIMAGE(R) Sestamibi with three regulators globally. We established a significant new contract for non-sterile products with Johnson & Johnson Consumer and broke ground on a second facility in the Montreal area that will help us service this new contract. We met our 2007 internal target for new business as part of our plan to replace declining production of Hectotol(R) injection. We successfully completed three FDA inspections, including two in the fourth quarter. We successfully concluded an agreement with GE Healthcare, a leader in the nuclear medicine sector, naming them as exclusive distributor of DRAXIMAGE(R) Sestamibi for the United States. We concluded an external evaluation of our MOLY-FILL(TM) Tc-99m Generator as part of the product development plan and in preparation for the next step in that product's regulatory review and approval process. We also completed upgrades to the Company's IT and SAP systems, including the installation of a new warehouse management system. All of these initiatives accomplished in 2007 bode well for the long term viability and growth of the Company going forward."

FINANCIAL HIGHLIGHTS

(in thousands of U.S. dollars except share related data and in accordance

with U.S. GAAP)

For the Three-Month Periods For the Years

Ended December 31, Ended December 31,

--------------------------- ----------------------


'/>"/>

SOURCE DRAXIS Health Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
2. DRAXIS to Present at the 2007 UBS Global Life Sciences Conference
3. DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer
4. DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
5. DRAXIS Announces Application for Normal Course Issuer Bid
6. DRAXIS Share Buyback Approved by TSX
7. DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th
8. Penn study finds pro-death proteins required to regulate healthy immune function
9. UCLA researchers identify markers that may predict diabetes in still-healthy people
10. Air pollution linked to cardiovascular risk indices in healthy young adults
11. More proof needed of safety and quality of electronic personal health records
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... GEORGIA (PRWEB) , ... July 01, 2015 , ... ... Institute for Biomedical Sciences at Georgia State University and a Georgia Research Alliance ... grant to develop novel anti-inflammatory therapeutics against middle-ear infections. , The grant from ...
(Date:7/1/2015)... York, NY (PRWEB) , ... July 01, 2015 , ... ... which DNA is wound, histones, remain constant in the brain, never changing after development ... have discovered that histones are steadily replaced in brain cells throughout life – a ...
(Date:7/1/2015)... ... July 01, 2015 , ... SuiteRx, innovative leaders in pharmacy ... pharmacy operations, announces the most recent positioning of SuiteRx CEO, Nicholas Zener Pharm. ... at the Venetian Las Vegas, Nevada. During this event, SuiteRx will be ...
(Date:7/1/2015)... ... July 01, 2015 , ... DIC ... plant for Linablue®, Spirulina-derived natural blue food coloring. Construction of the plant, which ... U.S. Spirulina* production base, began in May 2014. After commissioning, commercial production is ...
(Date:7/1/2015)... ... ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. ... Set for March 6th - 8th, the 2016 meeting will be held at the ... fundamentals of nasal surgery through the most modern advancements and updates in rhinoplasty and ...
Breaking Medicine News(10 mins):Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3
... , , LOS ANGELES, Sept. ... manufacturer of BPA-free baby bottles that provide a safe alternative ... currently banned in Canada, Minnesota, Connecticut and under scrutiny in ... Assembly members to support the Toxics-Free Babies and Toddlers ...
... of voting Iowans believe the government should be given additional ... them sick, according to a new poll commissioned by The ... Opinion Strategies. Support for stronger food protections is ... The statewide survey of 511 registered voters, conducted between August ...
... MOUNT LAUREL, N.J., Sept. 2 MedQuist Inc. (Nasdaq: ... a five-year $25 million revolving credit facility. The credit ... an option whereby the Company may increase its maximum credit ... The credit facility is a working capital facility that ...
... , , MONTREAL, ... in R&D, in partnership with industry leading manufacturers (Sirona, ... Systems today announced the launch of ProDrive products nationwide ... Dental Canada. Canada,s largest dental products reseller, Patterson has ...
... , , WASHINGTON, Sept. 2 ... to President Obama inviting him to address a Joint Session of Congress on Wednesday, ... text of the letter to the President: , , September ... , Washington, D.C. 20500 , , Dear Mr. President: , ...
... Md., Sept. 2 /PRNewswire-Asia/ -- Chindex International, Inc.,("Chindex") (Nasdaq: ... services in the People,s Republic of China, today,announced its participation in ... Healthcare Corporate Day, to be held September 11, 2009, ... institutional investors, throughout the day., ...
Cached Medicine News:Health News:BPA-Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for California's Toxics-Free Babies and Toddlers Act (SB 797) 2Health News:BPA-Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for California's Toxics-Free Babies and Toddlers Act (SB 797) 3Health News:BPA-Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for California's Toxics-Free Babies and Toddlers Act (SB 797) 4Health News:Pew poll: 9 in 10 Iowa voters support more government oversight of food 2Health News:MedQuist Announces Establishment of Revolving Credit Facility and Payment of Special Cash Dividend 2Health News:ProDrive Systems Announces Exclusive Distribution Agreement with Patterson Dental Canada 2Health News:Chindex International Announces September Investor Conferences Participation 2
(Date:7/1/2015)... 2015 Research and ... the "Future Horizons and Growth Strategies in ... and Country Forecasts" report to their offering. ... the European Blood Banking Market 2015 is a ... current suppliers and potential market entrants identify and ...
(Date:7/1/2015)... July 1, 2015  Celsion Corporation (NASDAQ: CLSN ... Michael H. Tardugno , Chairman, President and CEO, ... Healthcare Conference on Wednesday, July 8, 2015, at 4:15 ... Parker Meridien Hotel located at 119 W. 56th Street, ... A copy of the presentation will be available ...
(Date:7/1/2015)... (Continental) announced it is expanding its Baltimore -based clinical studies network and ... for unique patient populations.  Photo - ... ... ... "Continental hosts clinical studies for physicians ...
Breaking Medicine Technology:European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 3Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 3Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 4
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The ACMI™ line of laparoscopic hand instruments is designed to provide a wide selection of popular surgical devices to meet procedural needs....
Hook design lifts and separates tissue for efficient dissection. Cautery action facilitates immediate control of bleeders....
This probe coagulates bleeders while suction channel with trumpet valve simultaneously evacuates smoke....
Medicine Products: